Toscana virus associated with Guillain–Barré syndrome: a case–control study
Tóm tắt
Guillain–Barré syndrome (GBS) is an acute-onset, immune-mediated polyradiculoneuropathy, often precipitated by an antecedent infection. An association of GBS with vector-borne viral infections has been suggested, with evidence for the involvement of Zika, Dengue, Chikungunya and West Nile virus (WNV). This prospective case–control study was conducted to identify vector-borne viral infections in GBS. Thirteen individuals newly diagnosed as GBS were enrolled. Disease severity, prognostic factors and nerve conduction patterns were assessed. Eleven individuals with non-infectious conditions requiring cerebrospinal fluid (CSF) analysis were included as controls. Plasma, CSF and urine specimens were evaluated via nucleic acid amplification assays aimed to detect a broad spectrum of viruses. WNV and Toscana virus (TOSV) IgM/IgG antibodies were screened using commercial immunofluorescence assays and confirmed via virus neutralization tests (VNT). Partial TOSV nucleocapsid and genotype 1 polymerase sequences were detected in CSF of a patient with normal pressure hydrocephalus. Two control subjects had VNT-confirmed TOSV IgM in plasma. VNT-confirmed WNV and TOSV IgG were detected in 15.4% and 61.5% of GBS patients, respectively. Variations in WNV IgG and TOSV IgM detection rates were not statistically significant among study cohorts. However, TOSV IgG was significantly more frequent in GBS patients. No difference was observed for disease form or prognostic scores for virus markers. Follow-up serological profiles were identical to the initial findings. We have identified TOSV as a potential precipitating agent in GBS, with some rare clinical presentations of symptomatic TOSV infections.
Tài liệu tham khảo
Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain–Barré syndrome. Lancet 388:717–727
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC et al (2014) Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10:469–482
Willison HJ (2012) The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy. J Peripher Nerv Syst 17:3–8
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI et al (1998) The spectrum of antecedent infections in Guillain–Barré syndrome: a case–control study. Neurology 51:1110–1115
Salinas JL, Walteros DM, Styczynski A, Garzón F, Quijada H et al (2017) Zika virus disease-associated Guillain–Barré syndrome-Barranquilla, Colombia 2015–2016. J Neurol Sci 381:272–277
Parra B, Lizarazo J, Jiménez-Arango JA, Zea-Vera AF, González-Manrique G et al (2016) Guillain–Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med 375:1513–1523
Sahu R, Verma R, Jain A, Garg RK, Singh MK et al (2014) Neurologic complications in dengue virus infection: a prospective cohort study. Neurology 83:1601–1609
Davis LE, DeBiasi R, Goade DE, Haaland KY, Harrington JA et al (2006) West Nile virus neuroinvasive disease. Ann Neurol 60:286–300
Lebrun G, Chadda K, Reboux AH, Martinet O, Gaüzère BA (2009) Guillain–Barré syndrome after chikungunya infection. Emerg Infect Dis 15:495–496
Mancera-Páez O, Román GC, Pardo-Turriago R, Rodríguez Y, Anaya JM (2018) Concurrent Guillain–Barré syndrome, transverse myelitis and encephalitis post-Zika: a case report and review of the pathogenic role of multiple arboviral immunity. J Neurol Sci 395:47–53
Lynch RM, Mantus G, Encinales L, Pacheco N, Li G et al (2019) Augmented Zika and dengue neutralizing antibodies are associated with Guillain–Barré syndrome. J Infect Dis 219:26–30
Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA et al (2014) Diagnosis of Guillain–Barré syndrome and validation of Brighton criteria. Brain 137:33–43
van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA et al (2007) A clinical prognostic scoring system for Guillain–Barré syndrome. Lancet Neurol 6:589–594
Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW et al (2011) Early recognition of poor prognosis in Guillain–Barré syndrome. Neurology 76:968–975
Plasma Exchange/ Sandoglobulin Guillain–Barre´ syndrome trial group, Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP et al (1998) Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol 44:780–788
Van den Bergh PYK, Piéret F, Woodard JL, Attarian S, Grapperon AM et al (2018) Guillain–Barré syndrome subtype diagnosis: a prospective multicentric European study. Muscle Nerve. https://doi.org/10.1002/mus.26056
Sánchez-Seco MP, Echevarría JM, Hernández L, Estévez D, Navarro-Marí JM et al (2003) Detection and identification of Toscana and other phleboviruses by RT-nested-PCR assays with degenerated primers. J Med Virol 71:140–149
Charrel RN, Izri A, Temmam S, Delaunay P, Toga I et al (2007) Cocirculation of 2 genotypes of Toscana virus, southeastern France. Emerg Infect Dis 13:465–468
Vázquez A, Sánchez-Seco MP, Palacios G, Molero F, Reyes N et al (2012) Novel flaviviruses detected in different species of mosquitoes in Spain. Vector Borne Zoonotic Dis 12:223–229
Johnson DJ, Ostlund EN, Pedersen DD, Schmitt BJ (2001) Detection of North American West Nile virus in animal tissue by a reverse transcription-nested polymerase chain reaction assay. Emerg Infect Dis 7:739–741
Sanchez-Seco MP, Rosario D, Quiroz E, Guzman G, Tenorio A (2001) A generic nested-RT-PCR followed by sequencing for detection and identification of members of the alphavirus genus. J Virol Methods 95:153–161
Honig JE, Osborne JC, Nichol ST (2004) The high genetic variation of viruses of the genus Nairovirus reflects the diversity of their predominant tick hosts. Virology 318:10–16
Ergunay K, Gunay F, Erisoz Kasap O, Oter K, Gargari S et al (2014) Serological, molecular and entomological surveillance demonstrates widespread circulation of West Nile virus in Turkey. PLoS Negl Trop Dis 8:e3028
Ergünay K, Litzba N, Lo MM, Aydoğan S, Saygan MB et al (2011) Performance of various commercial assays for the detection of Toscana virus antibodies. Vector Borne Zoonotic Dis 11:781–787
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl Acids Res 22:4673–4680
Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549
Charrel RN, Gallian P, Navarro-Mari JM, Nicoletti L, Papa A et al (2005) Emergence of Toscana virus in Europe. Emerg Infect Dis 11:1657–1663
Ergunay K, Ayhan N, Charrel RN (2017) Novel and emergent sandfly-borne phleboviruses in Asia Minor: a systematic review. Rev Med Virol 27:e1898. https://doi.org/10.1002/rmv.1898
Baldelli F, Ciufolini MG, Francisci D, Marchi A, Venturi G et al (2004) Unusual presentation of life-threatening Toscana virus meningoencephalitis. Clin Infect Dis 38:515–520
Bartels S, de Boni L, Kretzschmar HA, Heckmann JG (2012) Lethal encephalitis caused by the Toscana virus in an elderly patient. J Neurol 259:175–177
Mosnier E, Charrel R, Vidal B, Ninove L, Schleinitz N et al (2013) Toscana virus myositis and fasciitis. Med Mal Infect 43:208–210
Oechtering J, Petzold GC (2012) Acute hydrocephalus due to impaired CSF resorption in Toscana virus meningoencephalitis. Neurology 79:829–831
Martínez-García FA, Moreno-Docón A, Segovia-Hernández M, Fernández-Barreiro A (2008) Deafness as a sequela of Toscana virus meningitis. Med Clin (Barc) 130:639
Sanbonmatsu-Gámez S, Pérez-Ruiz M, Palop-Borrás B, Navarro-Marí JM (2009) Unusual manifestation of toscana virus infection. Spain Emerg Infect Dis 15:347–348
Serata D, Rapinesi C, Del Casale A, Simonetti A, Mazzarini L et al (2011) Personality changes after Toscana virus (TOSV) encephalitis in a 49-year-old man: a case report. Int J Neurosci 121:165–169
Zanelli G, Bianco C, Cusi MG (2013) Testicular involvement during Toscana virus infection: an unusual manifestation? Infection 41:735–736
Ocal M, Orsten S, Inkaya AC, Yetim E, Acar NP et al (2014) Ongoing activity of Toscana virus genotype A and West Nile virus lineage 1 strains in Turkey: a clinical and field survey. Zoonoses Public Health 61:480–491
Rota E, Morelli N, Immovilli P, De Mitri P, Guidetti D (2017) Guillain–Barré-like axonal polyneuropathy associated with Toscana virus infection: a case report. Medicine (Baltimore) 96:e8081
Ergünay K, Saygan MB, Aydoğan S, Lo MM, Weidmann M et al (2011) Sandfly fever virus activity in central/northern Anatolia, Turkey: first report of Toscana virus infections. Clin Microbiol Infect 17:575–581
Magurano F, Nicoletti L (1999) Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays. Clin Diagn Lab Immunol 6:55–60
Ho TW, Willison HJ, Nachamkin I, Li CY, Veitch J et al (1999) Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann Neurol 45:168–173